Frances West, MD
Pulmonary Disease · Philadelphia, PANPI 1750608790
Payments from drug & device makers
Across 79 payments — averaging $495.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$25K
- Penumbra, Inc.$4K
- Exo Imaging, Inc.$4K
- Inari Medical, Inc.$3K
- Fujifilm Sonosite, Inc.$2K
- Mindray DS USA, Inc.$219
- plus $1K from 13 others
What the payments were for
- Consulting fees$4,20330%
- Speaking & faculty fees$2,00014%
- Travel & lodging$1,0387%
- Food & beverage$3,35024%
- Gifts$500%
- Other$3,50025%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 2 | $25,017 |
| Penumbra, Inc. | 12 | $3,959 |
| Exo Imaging, Inc. | 2 | $3,550 |
| Inari Medical, Inc. | 15 | $3,497 |
| Fujifilm Sonosite, Inc. | 9 | $1,619 |
| Mindray DS USA, Inc. | 3 | $219 |
| Innova Vascular Inc. | 1 | $160 |
| Boston Scientific | 1 | $156 |
| Philips North America LLC | 1 | $144 |
| GSK | 6 | $134 |
| Sanofi | 5 | $117 |
| Regeneron Healthcare Solutions, Inc. | 4 | $115 |
| AstraZeneca(2 entities) | 5 | $102 |
| GE HealthCare | 1 | $97 |
| Boehringer Ingelheim | 4 | $90 |
| Genentech USA, Inc. | 4 | $81 |
| Bayer | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Electromed, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$3,584
- Exo Iris$3,500
- FLOWTRIEVER CATHETER, S$3,200
- CT THROMBECTOMY SYSTEM KIT$3,200
- SonoSite PX$1,064
- Indigo$375
- M-Turbo Ultrasound System$364
- EKOSONIC$156
- (2585) 5500 WHC and POC Ultrasound System$144
- FlowTriever$120
- ClotTriever$120
- TE7 MAX$107
- TE X$107
How this compares
$39,142 in reported general payments places this provider in the 85th percentile of 703 pulmonary disease providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Philadelphia
- Gerard CrinerPhiladelphia$18.2M
- David WheelerPhiladelphia$7.7M
- Steven AlbeldaPhiladelphia$5.5M
- Steven KelsenPhiladelphia$847K
- Parth RaliPhiladelphia$814K
- Kartik ShenoyPhiladelphia$701K
- Christopher ManleyPhiladelphia$580K
- Michaela AndersonPhiladelphia$515K
- Michael BaramPhiladelphia$501K
- Ross SummerPhiladelphia$483K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.